AI-generated summary
The authors studied 22 university students aged 17 to 25 with anxiety and depression, dividing them into an LED treatment group and a placebo group. Participants were assessed at baseline and after 30 days using the hospital anxiety and depression scale and other tests. The authors report that 945-nm transcranial photobiomodulation may decrease anxiety and depression, though the reported group differences were partly not significant.
- Participants
- 22
- Who or what was studied
- University students aged 17 to 25 years with anxiety and depression
- Wavelengths
- 945 nm
- Limits stated in the abstract
- The sample was very small (11 per group) and the abstract reports that several comparisons did not reach significance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 9.35 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Anxiety, Transcranial photobiomodulation, Photobiomodulation, Wavelength, Light-emitting diode, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.